TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
12/04/2025
Back to search
Official data from USPTO
SEPSIA THERAPEUTICS
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
40
Latest update
04/03/2026
Trademark type
Combined
Nice classes
5, 10, 42
Filing date
10/26/2022
Registration date
11/19/2024
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
11/19/2024
Last transaction
04/03/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
3
Owner type
99
Owner location
ES
Examiner
DAVIS, MARC STEPHEN
Law office
N40
Current location
FILE REPOSITORY (FRANCONIA)
Mark description
The mark consists of the word "SEPSIA" in stylized capital letters, where the term "SEP" is in blue, and the term "SIA" is transparent appearing on a blue background in the form of a halved oblong shape. Below in stylized lowercase letters in blue is the wording "THERAPEUTICS". The color white represents background and is not a part of the mark.
Holders and representatives
Holders
SEPSIA THERAPEUTICS, S.L.
Representatives
Elizabeth Lee D'Amore Lucas & Mercanti, LLP
Technical classification
Nice Classes
Class 5Class 10Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical products namelypharmaceutical preparations for human and veterinary use for the treatment of infectious diseasesinflammatory conditionssepsisadvanced cell therapies and immunotherapy; biological preparations for medical and veterinary usebiological preparations for the treatment of infectious diseases; pharmaceuticalbiological and veterinary preparations for the treatment of infectious diseases and related inflammatory processesfor the treatment of sepsis and for advanced cell therapies and immunotherapy; pharmaceutical preparations containing nucleic acids and proteins and active peptides for medical and veterinary usepharmaceutical preparations containing nucleic acids and proteins and active peptides for the treatment of infectious diseases and related inflammatory processesfor the treatment of sepsis and for advanced cell therapies and immunotherapy
Class 10
Medical machines for dialysishemoperfusion and hemoadsorption; medical devices for blood purificationhemoperfusion machines; medical adsorption devices and polymeric adsorption materials for the removal of materials from the blood or from blood fractions and kits primarily containing said testing devices for the identification of bacteria for medical use; electrical instruments for medical use in blood diagnostic analysis; assay instruments for medical diagnostic use in measuringtesting and analyzing bloodbody fluidscellsproteinspeptides and nucleic acids for infectious diseases and associated inflammatory processessepsis and in advanced cell therapies and immunotherapy; medical diagnostic testing instruments for use in immunoassay procedures; diagnostic apparatus for medical use in measuringtesting and analyzing bloodbody fluidscellsproteinspeptides and nucleic acids for infectious diseases and associated inflammatory processessepsis and in advanced cell therapies and immunotherapy; medical diagnostic testing apparatus for use in measuringtesting and analyzing bloodbody fluidscellsproteinspeptides and nucleic acids for immunoassay procedures; apparatus and instruments for diagnostic testing for medical purposes in measuringtesting and analyzing bloodbody fluidscellsproteinspeptides and nucleic acids for infectious diseases and associated inflammatory processessepsis and in advanced cell therapies and immunotherapy; apparatus and instruments for veterinary diagnosis in measuringtesting and analyzing bloodbody fluidscellsproteinspeptides and nucleic acids for infectious diseases and associated inflammatory processessepsis and in advanced cell therapies and immunotherapy; medical diagnostic instruments for diagnosis in measuringtesting and analyzing bloodbody fluidscellsproteinspeptides and nucleic acids for infectious diseases and associated inflammatory processessepsis and in advanced cell therapies and immunotherapy; dialysis apparatusdialysis and hemofiltration machines; dialysis machines for veterinary usedialysis and hemofiltration machines; dialysis machines for medical use
Class 42
Scientific and technological servicesas well as associated research and design servicesscientific research and development in the fields of biochemicalspharmacymedicine and veterinary medicine; industrial analysis services related to biologybiochemistrychemistrypharmacymedicine and veterinary medicineindustrial research in the fields of biologybiochemistrychemistrypharmacymedicine and veterinary medicine; scientific research services related to biologybiochemistrychemistrypharmacymedicine and veterinary medicine; scientific research services related to the treatment of infectious diseases and related inflammatory processessepsis and advanced cell therapies and immunotherapy; scientific research services related to peptides and proteins for pharmaceuticalmedical and veterinary use
Publications
History of USPTO decisions and trademark events.
40 publications found
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
12/04/2025
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
12/04/2025
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
12/04/2025
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
05/03/2025
FICS
FINAL DISPOSITION NOTICE SENT TO IB
04/14/2025
FIMP
FINAL DISPOSITION PROCESSED
04/14/2025
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
02/19/2025
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
11/19/2024
R.PR
REGISTERED-PRINCIPAL REGISTER
11/19/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
09/03/2024
PUBO
PUBLISHED FOR OPPOSITION
09/03/2024
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
08/17/2024
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
08/14/2024
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
07/31/2024
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
07/31/2024
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
07/25/2024
XAEC
EXAMINER'S AMENDMENT ENTERED
07/25/2024
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
07/25/2024
GNEA
EXAMINERS AMENDMENT E-MAILED
07/25/2024
CNEA
EXAMINERS AMENDMENT -WRITTEN
07/25/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
07/24/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
07/24/2024
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
07/24/2024
RFNT
REFUSAL PROCESSED BY IB
03/26/2024
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
02/25/2024
GNRT
NON-FINAL ACTION E-MAILED
02/25/2024
CNRT
NON-FINAL ACTION WRITTEN
02/25/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
01/25/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
01/24/2024
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
01/24/2024
RFNT
REFUSAL PROCESSED BY IB
10/04/2023
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
09/11/2023
RFRR
REFUSAL PROCESSED BY MPU
09/11/2023
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
08/19/2023
CNRT
NON-FINAL ACTION WRITTEN
08/18/2023
DOCK
ASSIGNED TO EXAMINER
08/10/2023
MAFR
APPLICATION FILING RECEIPT MAILED
03/07/2023
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
03/03/2023
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
03/02/2023
Continuous trademark protection
Get notified about every new filing that threatens SEPSIA THERAPEUTICS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.